Search Results - "Kowalski, Aaron"

Refine Results
  1. 1
  2. 2

    Glucose Management Indicator (GMI): A New Term for Estimating A1C From Continuous Glucose Monitoring by Bergenstal, Richard M, Beck, Roy W, Close, Kelly L, Grunberger, George, Sacks, David B, Kowalski, Aaron, Brown, Adam S, Heinemann, Lutz, Aleppo, Grazia, Ryan, Donna B, Riddlesworth, Tonya D, Cefalu, William T

    Published in Diabetes care (01-11-2018)
    “…While A1C is well established as an important risk marker for diabetes complications, with the increasing use of continuous glucose monitoring (CGM) to help…”
    Get full text
    Journal Article
  3. 3
  4. 4
  5. 5

    Can we really close the loop and how soon? Accelerating the availability of an artificial pancreas: a roadmap to better diabetes outcomes by Kowalski, Aaron J

    Published in Diabetes technology & therapeutics (15-06-2009)
    “…Development of a closed-loop artificial pancreas has been a long-time goal that could transform diabetes management. The primary limitation until recent years…”
    Get more information
    Journal Article
  6. 6
  7. 7
  8. 8
  9. 9
  10. 10
  11. 11
  12. 12
  13. 13

    Pathway to artificial pancreas systems revisited: moving downstream by Kowalski, Aaron

    Published in Diabetes care (01-06-2015)
    “…Artificial pancreas (AP) systems, a long-sought quest to replicate mechanically islet physiology that is lost in diabetes, are reaching the clinic, and the…”
    Get full text
    Journal Article
  14. 14
  15. 15

    PsychDT Working Group: Report Psychosocial Aspects of Artificial Pancreas Systems by Barnard, Katharine D., Venkat, Manu V., Close, Kelly, Heinemann, Lutz, Weissberg-Benchell, Jill, Hood, Korey K., Kubiak, Thomas, Kowalski, Aaron J., Laffel, Lori

    Published in Journal of diabetes science and technology (01-07-2015)
    “…Background: Diabetes technology is a cornerstone of diabetes management in the 21st century, with advances in available devices over recent years playing a…”
    Get full text
    Journal Article
  16. 16

    Characterization of anti-osteopontin monoclonal antibodies: Binding sensitivity to post-translational modifications by Kazanecki, Christian C., Kowalski, Aaron J., Ding, Tony, Rittling, Susan R., Denhardt, David T.

    Published in Journal of cellular biochemistry (01-11-2007)
    “…Osteopontin (OPN) is primarily a secreted phosphoglycoprotein found in a variety of tissues and body fluids. It has a wide range of reported functions, many of…”
    Get full text
    Journal Article
  17. 17

    Increased expression of the remodeling- and tumorigenic-associated factor osteopontin in pyramidal neurons of the Alzheimer's disease brain by Wung, John K, Perry, George, Kowalski, Aaron, Harris, Peggy L R, Bishop, Glenda M, Trivedi, Mehul A, Johnson, Sterling C, Smith, Mark A, Denhardt, David T, Atwood, Craig S

    Published in Current Alzheimer research (01-02-2007)
    “…Osteopontin (OPN) is a glycophosphoprotein expressed by several cell types and has pro-adhesive, chemotactic, and cytokine-like properties. OPN is involved in…”
    Get more information
    Journal Article
  18. 18

    Regulation of Collagenase-3 and Osteocalcin Gene Expression by Collagen and Osteopontin in Differentiating MC3T3-E1 Cells by D'Alonzo, Richard C., Kowalski, Aaron J., Denhardt, David T., Nickols, G. Allen, Partridge, Nicola C.

    Published in The Journal of biological chemistry (05-07-2002)
    “…Both collagenase-3 and osteocalcin mRNAs are expressed maximally during the later stages of osteoblast differentiation. Here, we demonstrate that collagenase-3…”
    Get full text
    Journal Article
  19. 19

    Type 1 diabetes: from the dream of automated insulin delivery to a fully artificial pancreas by Phillip, Moshe, Kowalski, Aaron, Battelino, Tadej

    Published in Nature medicine (01-05-2024)
    “…Automated insulin delivery systems have transformed the care of people living with type 1 diabetes and continue to move closer to the ultimate goal of a fully…”
    Get full text
    Journal Article
  20. 20

    Mice Lacking Osteopontin Show Normal Development and Bone Structure but Display Altered Osteoclast Formation In Vitro by Rittling, Susan R., Matsumoto, Hiroko N., Mckee, Marc D., Nanci, Antonio, An, Xiao‐Rong, Novick, Kristine E., Kowalski, Aaron J., Noda, Masaki, Denhardt, David T.

    Published in Journal of bone and mineral research (01-07-1998)
    “…We have used homologous recombination in embryonic stem cells to generate mice with a targeted disruption of the osteopontin (Opn, or Spp1, for secreted…”
    Get full text
    Journal Article